换一批The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment.
第一作者：
Boris,Lin
第一单位：
Jerome Lipper Multiple Myeloma Center, Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
作者：
主题词
骨髓(Bone Marrow);细胞黏附(Cell Adhesion);细胞分裂(Cell Division);细胞运动(Cell Movement);地塞米松(Dexamethasone);药物协同作用(Drug Synergism);细胞外基质蛋白质类(Extracellular Matrix Proteins);人类(Humans);白细胞介素6(Interleukin-6);多发性骨髓瘤(Multiple Myeloma);磷酰化(Phosphorylation);酞嗪类(Phthalazines);原癌基因蛋白质类c-kit(Proto-Oncogene Proteins c-kit);吡啶类(Pyridines);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases);受体, 生长因子(Receptors, Growth Factor);受体, 血管内皮生长因子(Receptors, Vascular Endothelial Growth Factor);肿瘤细胞, 培养的(Tumor Cells, Cultured);血管内皮生长因子受体1(Vascular Endothelial Growth Factor Receptor-1);血管内皮生长因子受体3(Vascular Endothelial Growth Factor Receptor-3)
PMID
12208756
发布时间
2018-11-30
- 浏览25
Cancer research
5019-26页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
